Warfarin GenoStat Test update

Iverson Genetic began the double-blind, U.S. WARFARIN trial to evaluate the use of its Warfarin GenoSTAT Test to determine warfarin dosing in 4,300 patients. CMS authorized the trial to gather data fo...